Nicotine Science and Policy
By Harry Shapiro Aug. 13, 2026
Harry's blog 134: Filtering out lies and misinformation
The only major global journal focused on harm reduction has gone bust. Since 2017, Filter has advocated through journalism for rational and compassionate approaches to drug use, drug policy and human rights, while also standing out for its coverage of tobacco harm reduction. Its closure is a significant loss - particularly at a time when well-funded opponents of tobacco harm reduction continue to thrive.
September 02, 2026 by worldvapersalliance.com
The US is moving fast on pouches, the EU should follow its lead
The US approach to nicotine pouches shows a more practical way to handle smoke-free innovation. Rather than treating the category as a threat by default, regulators can assess products through evidence, standards and their potential role in moving adults away from cigarettes. Europe should not fall behind by regulating pouches as though all nicotine use carries the same public health meaning. A risk-proportionate framework would protect young people while allowing lower-risk alternatives to compete with combustible tobacco.
September 02, 2026 by planetofthevapes.co.uk
Experts React to Cochrane Findings
Expert reaction to the latest Cochrane findings should move the vaping debate closer to clinical reality. Nicotine vapes have stronger evidence for helping people quit smoking than many critics are willing to acknowledge, especially for adults who have struggled with other methods. That does not make vaping risk-free or suitable for non-smokers. It means cessation advice should reflect the evidence clearly enough to help smokers leave combustion behind.
September 02, 2026 by dcjournal.com
Adult Smokers Deserve the Truth About Nicotine Risk
Adult smokers deserve more than warnings that blur every nicotine product into the same risk category. The truth is that smoking causes harm primarily through combustion, while smoke-free alternatives can reduce exposure for those who switch completely. Accurate risk communication does not minimise nicotine dependence; it helps people understand where the greatest danger lies. Public health should trust adults with clear information, especially when that information could help them leave cigarettes behind.
September 01, 2026 by substack.com
Two Countries, the Same Evidence, and Two Very Different Ideas About Helping Smokers Quit
The same evidence can lead two countries in opposite directions. One government may see safer nicotine products as part of the route away from smoking, while another treats them as a problem to restrict alongside cigarettes. That difference is not scientific; it is political. Public health policy should be judged by what it enables smokers to do in practice, not by how tightly it defends old assumptions.
September 01, 2026 by tidsskriftet.no
Changing nicotine preferences in a stable market
Changing nicotine preferences do not necessarily indicate a shrinking nicotine market. They can mean a shift in how people consume nicotine: away from cigarettes and towards pouches, snus, vaping or heated tobacco. That distinction matters because public health outcomes depend on the form of use, not only the presence of nicotine itself. A stable market can still become less harmful when policy helps consumers move away from combustion.
Blogs
Harry's blog 134: Filtering out lies and misinformation
The only major global journal focused on harm reduction has gone bust. Since 2017, Filter has advocated through journalism for rational and compassionate approaches to drug use, drug policy and human rights, while also standing out for its coverage of tobacco harm reduction. Its closure is a significant loss - particularly at a time when well-funded opponents of tobacco harm reduction continue to thrive.
Harry’s blog 133: Silence is consent
Two tobacco control consultations that demand your attention
I’m sure there are many of you like me who are deeply cynical about public consultations. They often feel like political tick box exercises allowing the issuing authority from local councils to international organisations to say they have ‘consulted with the people’, when in truth they knew exactly what they were going to do from the get-go.
Harry’s Blog 132: “Zyn! Went The Strings Of My Heart” (with apologies to Judy Garland)
FDA approval of 20 nicotine pouch products is another step forward for tobacco harm reduction
The FDA in the U.S. has granted marketing authorisation for Zyn nicotine pouch products (five variations on mint plus five other flavours in two different strengths).
In its letter to PMI (who own Zyn manufacturers Swedish Match), the FDA wrote:
Based on our review of your MRTPAs [Modified Risk Tobacco Applications] we determined that the proposed modified risk tobacco products, …as actually used by consumers would significantly reduce harm and the risk of tobacco-related disease to individual tobacco users and benefit the health of the population as a whole, taking into account both users of tobacco products and persons who do not currently use tobacco products. Therefore, we authorize marketing of the tobacco products as modified risk tobacco products with the following modified risk information – “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis”.